Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Aspivix Joins Afaxys GPO to Expand Access to carevix® Across the U.S. Public Health Community
The new agreement gives Afaxys members access to carevix®, an FDA-cleared cervical stabilizer, clinically proven to reduce pain and bleeding during IUD insertion procedures. LOS ANGELES – October 19, 2026 – Aspivix,...
Revolutionizing Gynecology with Women in Mind: Why Patient-Centered Innovation Matters
For generations, women's experiences during routine gynecological procedures have often been overlooked. Pain, discomfort, and anxiety have been accepted as an unavoidable part of care, with many patients hearing phrases like, "It's...
Aspivix Achieves New Milestone: Study Results Peer-Reviewed and Published in the International Journal of Gynecology & Obstetrics
A multicenter post-marketing study reveals safety and efficacy of carevix® in gynecological IUD insertion procedures LOS ANGELES, Feb. 5, 2026 — Aspivix - a FemTech company dedicated to modernizing gynecological care - announced the...
Leading the Way in Women’s Health Innovation
💡 Celebrating Women in MedTech: Ikram Guerd 💡 Thank you to Women of Wearables (WoW) for spotlighting the work we are doing at Aspivix and our GM U.S. & CMO, Ikram Guerd....
An unsung hero in Femtech
Behind every breakthrough in women’s health, there are innovators working quietly, relentlessly, and with purpose. We’re proud to spotlight our CTO and co-founder, Julien Finci, an engineer who helped challenge a century-old...
“Must IUD insertion really be this painful?”
This question is now being asked openly — and rightfully so — in a newly published article addressing pain during IUD insertion. At Aspivix, this question has guided our work from day...
